Latest Earnings Analysis

• STEM (STEM) Q4 2025: Software and Services Revenue Climbs 25% as Operating Model Shifts
  March 05, 2026 · STEM
• OOMA (OOMA) Q4 2026: Adjusted EBITDA Margin Rises to 15% as Airdial and Acquisitions Drive Expansion
  March 05, 2026 · OOMA
• MagnaChip (MX) Q4 2025: R&D Investment Surges 44% as 55 New Products Target Margin Recovery
  March 05, 2026 · MX
• Cross Country Healthcare (CCRN) Q4 2025: Home-Based Staffing Revenue Jumps 34%, Technology-Led Margin Expansion in Focus
  March 05, 2026 · CCRN
• Broadcom (AVGO) Q1 2026: AI Semiconductor Revenue Surges 106%, Unlocking $100B+ 2027 Visibility
  March 05, 2026 · AVGO
• SES (SES) Q4 2025: ESS Revenue Jumps to 65% Mix as Drone, Materials Ramp Nears
  March 05, 2026 · SES
• Hyster-Yale (HY) Q4 2025: Bookings Surge 42% as Replacement Demand Cycle Emerges
  March 04, 2026 · HY
• VersaBank (VBNK) Q1 2026: U.S. SRP Portfolio Jumps 29%, Unlocking Operating Leverage
  March 04, 2026 · VBNK
• Grand Tierra Energy (GTE) Q4 2025: 32% Production Growth Drives Portfolio Diversification, Debt Reduction Focus
  March 04, 2026 · GTE
• Horizon Technology Finance (HRZN) Q4 2025: Backlog Rises to $154M as Merger Scale Unlocks Venture Lending Capacity
  March 04, 2026 · HRZN
• Bath & Body Works (BBWI) Q4 2025: $250M Cost Initiative Funds Brand Overhaul as Innovation Lags Growth
  March 04, 2026 · BBWI
• Daktronics (DAKT) Q3 2026: Backlog Climbs 25% as Live Events, Transportation Fuel Multi-Quarter Visibility
  March 04, 2026 · DAKT
• EYPT Q4 2025: R&D Spend Climbs 45% as DuraView Nears Phase III Data Inflection
  March 04, 2026 · EYPT
• RYAM (RYAM) Q4 2025: Cellulose Specialties Prices Up 18% as Leadership Targets Positive Cash Flow Turnaround
  March 04, 2026 · RYAM
• Riskified (RSKD) Q4 2025: Non-U.S. Revenue Climbs to 46% as Platform Diversifies
  March 04, 2026 · RSKD
• Stevanato Group (STVN) Q4 2025: High-Value Solutions Rise to 49% of Revenue, Anchoring Margin Expansion
  March 04, 2026 · STVN
• Nexen (NEXN) Q4 2025: Programmatic Revenue Set to Grow 10% as CTV and AI Investments Scale
  March 04, 2026 · NEXN
• MEC (MEC) Q4 2025: Data Center Pipeline Surges to $125M as Cross-Selling Synergies Accelerate
  March 04, 2026 · MEC
• Ocugen (OCGN) Q4 2025: OCU410 Shows 46% Lesion Reduction, Accelerating Gene Therapy Pipeline Milestones
  March 04, 2026 · OCGN
• Holley (HLLY) Q4 2025: Core Sales Surge 13.5% as Margin Expansion Anchors Transformation
  March 04, 2026 · HLLY
• FuelTech (FTEK) Q4 2025: Data Center Pipeline Swells to $100M as Segment Backlog Rises 13%
  March 04, 2026 · FTEK
• Altisource (ASPS) Q4 2025: HUBZoo Inventory Surges 137%, Offsetting Rhythm Revenue Loss
  March 04, 2026 · ASPS
• Wix (WIX) Q4 2025: Base44 ARR Surges to $100M, Unlocking New AI-Driven Market Reach
  March 04, 2026 · WIX
• Orion Group Holdings (ORN) Q4 2025: $23B Pipeline Expands, Data Centers Reach 40% of Concrete Mix
  March 04, 2026 · ORN
• Dycom (DY) Q4 2026: Backlog Hits $9.5B as Data Center and Fiber Demand Accelerate
  March 04, 2026 · DY
• AFCG Q4 2025: $1.4B Pipeline Emerges as BDC Conversion Unlocks Lending Flexibility
  March 04, 2026 · AFCG
• SmartRent (SMRT) Q4 2025: Core Revenue Rises 12% as Installed Base Marches Toward 1 Million Units
  March 04, 2026 · SMRT
• Abercrombie & Fitch (ANF) Q4 2025: Tariffs Add $90M Cost Drag as Operating Model Delivers Double-Digit Margins
  March 04, 2026 · ANF
• Wallbox (WBX) Q4 2025: Gross Margin Surges 410bps as Sales Refocus Drives Leaner Model
  March 04, 2026 · WBX
• Brown-Forman (BRO) Q3 2026: RTD Portfolio Drives 15% Emerging Market Growth Amid Developed Market Weakness
  March 04, 2026 · BRO
• Genius Sports (GENI) Q4 2025: Legend Deal Accelerates Path to $1.1B Revenue, 30% Margin
  March 04, 2026 · GENI
• National Vision (EYE) Q4 2025: Managed Care Climbs to 42% of Revenue, Accelerating Margin Expansion
  March 04, 2026 · EYE
• Tidewater (TDW) Q4 2025: $500M Wilson Sons Acquisition Accelerates Brazil Expansion
  March 04, 2026 · TDW
• James River Group (JRVR) Q4 2025: Expense Ratio Falls by 2.5 Points as Profitability Focus Reshapes E&S Platform
  March 04, 2026 · JRVR
• Supervielle (SUPV) Q4 2025: Corporate Loans Surge 25% as Asset Quality Peaks, Capital Buffer Holds
  March 04, 2026 · SUPV
• Crescendo (CXDO) Q4 2025: ESI Acquisition Adds $26M Revenue, Accelerates Path to $100M Target
  March 04, 2026 · CXDO
• Target (TGT) Q4 2025: $2B Store Investment Signals Broad-Based Merchandising Reset
  March 04, 2026 · TGT
• Ascent Industries (ACNT) Q4 2025: Gross Margin Expands 1,000bps on Structural Shift, Despite 7% Revenue Drop
  March 04, 2026 · ACNT
• Cryoport (CYRX) Q4 2025: Commercial Cell & Gene Therapy Revenue Surges 29%, Anchoring Long-Term Growth
  March 04, 2026 · CYRX
• CrowdStrike (CRWD) Q4 2026: Falcon Flex ARR Surges 120% as AI Security Drives Platform Expansion
  March 04, 2026 · CRWD
• LB Foster (FSTR) Q4 2025: Backlog Climbs 15%, Resetting Rail and Infrastructure Growth Trajectory
  March 04, 2026 · FSTR
• SoundThinking (SSTI) Q4 2025: ARR Set to Climb 15% as SafePoint and Plate Ranger Accelerate
  March 04, 2026 · SSTI
• CPS Technologies (CPSH) Q4 2025: Facility Expansion Unlocks Capacity as Gold Costs Pressure Margins
  March 04, 2026 · CPSH
• BBVA (BBVA) Q4 2025: Loan Book Climbs 16% as Capital Allocation Tightens
  March 04, 2026 · BBVA
• Ross Stores (ROST) Q4 2025: 21% EPS Growth Marks Inflection as Store Expansion Accelerates
  March 04, 2026 · ROST
• Cumberland Pharmaceuticals (CPIX) Q4 2025: Vibative, Sancuso, and Talicia Drive 31% Revenue Surge, Global Expansion Accelerates
  March 04, 2026 · CPIX
• Arcturus Therapeutics (ARCT) Q4 2025: Cash Runway Extended to 2028 as Rare Disease Pipeline Advances
  March 04, 2026 · ARCT
• BWLP (BWLP) Q4 2025: U.S. Spot Rates Jump to $80,000 as Middle East Disruption Redraws LPG Trade
  March 04, 2026 · BWLP
• STAAR Surgical (STAA) Q4 2025: Operating Expenses Down 8%, Pivots to Growth and Innovation After China Reset
  March 04, 2026 · STAA
• Rigel Pharmaceuticals (RIGL) Q4 2025: Net Product Sales Jump 60% as Portfolio Expansion Accelerates Cash Generation
  March 04, 2026 · RIGL